Literature DB >> 25166938

Factors associated with recurrent Plasmodium vivax malaria in Porto Velho, Rondônia State, Brazil, 2009.

Luciano Rodrigues Simões1, Eduardo Rodrigues Alves1, Daniele Ribatski-Silva1, Luciano Teixeira Gomes1, Andréia Ferreira Nery1, Cor Jesus Fernandes Fontes1.   

Abstract

This open retrospective cohort study aimed to describe the incidence of recurrent Plasmodium vivax malaria and associated factors in Porto Velho, Rondônia State, Brazil, in 2009. Data were collected from the National Information System for Malaria Epidemiological Surveillance. There were 23,365 reported P. vivax malaria cases in 2009, 23% of which were classified as relapses. Incidence density of P. vivax recurrence was 45.1/100 patient-years, mostly occurring between the 4th and 13th week after initiating treatment. Male gender, shorter time since onset of symptoms, and higher parasitemia in the initial infection increased the risk of relapse during the year, with a 10% reduction in relative risk for longer symptoms and 11% and 15% increases in relative risk for males and higher initial parasitemia, respectively. However, the results show low clinical relevance for these associations, thereby limiting their applicability to decision-making at the public health level.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25166938     DOI: 10.1590/0102-311x00169312

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  11 in total

1.  Doses of primaquine administered to children with Plasmodium vivax according to an age-based dose regimen.

Authors:  Michelle Valeria Dias Ferreira Vieira; Tamyris Regina Matos Lopes; Amanda Gabryelle Nunes Cardoso Mello; Luann Wendel Pereira de Sena; Robert J Commons; José Luiz Fernandes Vieira
Journal:  Pathog Glob Health       Date:  2020-07-24       Impact factor: 2.894

2.  Novel Insights into Plasmodium vivax Therapeutic Failure: CYP2D6 Activity and Time of Exposure to Malaria Modulate the Risk of Recurrence.

Authors:  Ana Carolina Rios Silvino; Flora Satiko Kano; Marcelo Azevedo Costa; Cor Jesus Fernandes Fontes; Irene Silva Soares; Cristiana Ferreira Alves de Brito; Luzia Helena Carvalho; Tais Nobrega Sousa
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

3.  Prevalence and force of Plasmodium vivax blood-stage infection and associated clinical malaria burden in the Brazilian Amazon.

Authors:  Wuelton Monteiro; Stephan Karl; Andrea Kuehn; Anne Almeida; Michael White; Sheila Vitor-Silva; Gisely Melo; Jose Diego Brito-Sousa; Djane Clarys Baia-da-Silva; Alexandre Vilhena Silva-Neto; Vanderson Sampaio; Quique Bassat; Ingrid Felger; Ivo Mueller; Marcus Lacerda
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-06-24       Impact factor: 2.747

4.  Plasmodium vivax Landscape in Brazil: Scenario and Challenges.

Authors:  Andre M Siqueira; Oscar Mesones-Lapouble; Paola Marchesini; Vanderson de Souza Sampaio; Patricia Brasil; Pedro L Tauil; Cor Jesus Fontes; Fabio T M Costa; Cláudio Tadeu Daniel-Ribeiro; Marcus V G Lacerda; Camila P Damasceno; Ana Carolina S Santelli
Journal:  Am J Trop Med Hyg       Date:  2016-10-05       Impact factor: 2.345

5.  Fixed-Dose Artesunate-Amodiaquine Combination vs Chloroquine for Treatment of Uncomplicated Blood Stage P. vivax Infection in the Brazilian Amazon: An Open-Label Randomized, Controlled Trial.

Authors:  Andre M Siqueira; Aline C Alencar; Gisely C Melo; Belisa L Magalhaes; Kim Machado; Aristóteles C Alencar Filho; Andrea Kuehn; Marly M Marques; Monica Costa Manso; Ingrid Felger; José L F Vieira; Valerie Lameyre; Claudio T Daniel-Ribeiro; Marcus V G Lacerda
Journal:  Clin Infect Dis       Date:  2016-10-20       Impact factor: 9.079

6.  Short-Time Recurrences of Plasmodium vivax Malaria as a Public Health Proxy for Chloroquine-Resistance Surveillance: A Spatio-Temporal Study in the Brazilian Amazon.

Authors:  Antonio A S Balieiro; Andre M Siqueira; Gisely C Melo; Wuelton M Monteiro; Vanderson S Sampaio; Ivo Mueller; Marcus V G Lacerda; Daniel A M Villela
Journal:  Int J Environ Res Public Health       Date:  2021-05-11       Impact factor: 3.390

Review 7.  Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date.

Authors:  Yehenew A Ebstie; Solomon M Abay; Wondmagegn T Tadesse; Dawit A Ejigu
Journal:  Drug Des Devel Ther       Date:  2016-07-26       Impact factor: 4.162

8.  A clinical tool to predict Plasmodium vivax recurrence in Malaysia.

Authors:  Norliza Mat Ariffin; Farida Islahudin; Endang Kumolosasi; Mohd Makmor-Bakry
Journal:  BMC Infect Dis       Date:  2017-12-08       Impact factor: 3.090

9.  Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.

Authors:  Rodrigo M Corder; Antonio C P de Lima; David S Khoury; Steffen S Docken; Miles P Davenport; Marcelo U Ferreira
Journal:  PLoS Negl Trop Dis       Date:  2020-07-31

10.  Factors associated with malaria in indigenous populations: A retrospective study from 2007 to 2016.

Authors:  Bruna Martins Meireles; Vanderson de Souza Sampaio; Wuelton Marcelo Monteiro; Maria Jacirema Ferreira Gonçalves
Journal:  PLoS One       Date:  2020-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.